Title:
【発明の名称】新規な融合タンパク質、その遺伝子、組み換えベクター、及び組み換えウイルスとその利用
Document Type and Number:
Japanese Patent JP3357071
Kind Code:
B2
Abstract:
A DNA coding for a fusion protein comprising a polypeptide having the antigenicity of Mycoplasma gallisepticum and a polypeptide derived from Herpesvirus outer membrane protein, in which the polypeptide derived from the outer membrane protein has been ligated with the polypeptide having the antigenicity of Mycoplasma gallisepticum at the N terminus thereof, is prepared. The DNA is inserted into a region non-essential to growth of Avipox virus and the resulting recombinant Avipox virus is provided as a more potent recombinant virus as an anti-Mycoplasma vaccine.
Inventors:
Shuji Saito
Yoshinari Tsuzaki
Noboru Yanagita
Yoshinari Tsuzaki
Noboru Yanagita
Application Number:
JP53512997A
Publication Date:
December 16, 2002
Filing Date:
March 28, 1997
Export Citation:
Assignee:
Nippon Zeon Co., Ltd.
International Classes:
C07K14/035; C07K14/055; C07K14/30; C12N15/31; C12N15/863; A61K39/00; (IPC1-7): C07K14/30; A61K39/255; A61P31/00; C07K14/055; C07K14/065; C07K19/00; C12N7/00; C12N15/09
Other References:
【文献】国際公開94/23019(WO,A1)
Attorney, Agent or Firm:
Akira Asamura (3 outside)